vs

Side-by-side financial comparison of Capstone Holding Corp. (CAPS) and Silence Therapeutics plc (SLN). Click either name above to swap in a different company.

Silence Therapeutics plc is the larger business by last-quarter revenue ($15.7M vs $14.0M, roughly 1.1× Capstone Holding Corp.). Capstone Holding Corp. runs the higher net margin — -14.4% vs -14.7%, a 0.3% gap on every dollar of revenue.

Capstone Green Energy Corporation, formerly Capstone Turbine Corporation, was incorporated in 1988 as a California based gas turbine manufacturer that specializes in microturbine power along with heating and cooling cogeneration systems. Key to the Capstone design is its use of air bearings, which provides maintenance and fluid-free operation for the lifetime of the turbine and reduces the system to a single moving part. This also eliminates the need for any cooling or other secondary systems...

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

CAPS vs SLN — Head-to-Head

Bigger by revenue
SLN
SLN
1.1× larger
SLN
$15.7M
$14.0M
CAPS
Higher net margin
CAPS
CAPS
0.3% more per $
CAPS
-14.4%
-14.7%
SLN

Income Statement — Q3 FY2025 vs Q1 FY2024

Metric
CAPS
CAPS
SLN
SLN
Revenue
$14.0M
$15.7M
Net Profit
$-2.0M
$-2.3M
Gross Margin
23.3%
82.2%
Operating Margin
-5.5%
-35.6%
Net Margin
-14.4%
-14.7%
Revenue YoY
Net Profit YoY
EPS (diluted)
$-0.35
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAPS
CAPS
SLN
SLN
Q3 25
$14.0M
Q2 25
$13.2M
Q1 25
$8.2M
Q1 24
$15.7M
Net Profit
CAPS
CAPS
SLN
SLN
Q3 25
$-2.0M
Q2 25
$-700.0K
Q1 25
$-1.7M
Q1 24
$-2.3M
Gross Margin
CAPS
CAPS
SLN
SLN
Q3 25
23.3%
Q2 25
23.7%
Q1 25
16.2%
Q1 24
82.2%
Operating Margin
CAPS
CAPS
SLN
SLN
Q3 25
-5.5%
Q2 25
-2.0%
Q1 25
-17.5%
Q1 24
-35.6%
Net Margin
CAPS
CAPS
SLN
SLN
Q3 25
-14.4%
Q2 25
-5.3%
Q1 25
-21.2%
Q1 24
-14.7%
EPS (diluted)
CAPS
CAPS
SLN
SLN
Q3 25
$-0.35
Q2 25
$-0.13
Q1 25
$-0.47
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAPS
CAPS
SLN
SLN
Cash + ST InvestmentsLiquidity on hand
$730.0K
Total DebtLower is stronger
$11.7M
Stockholders' EquityBook value
$27.2M
$156.8M
Total Assets
$58.5M
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAPS
CAPS
SLN
SLN
Q3 25
$730.0K
Q2 25
$773.0K
Q1 25
$1.7M
Q1 24
Total Debt
CAPS
CAPS
SLN
SLN
Q3 25
$11.7M
Q2 25
$9.6M
Q1 25
$8.8M
Q1 24
Stockholders' Equity
CAPS
CAPS
SLN
SLN
Q3 25
$27.2M
Q2 25
$26.3M
Q1 25
$27.0M
Q1 24
$156.8M
Total Assets
CAPS
CAPS
SLN
SLN
Q3 25
$58.5M
Q2 25
$51.9M
Q1 25
$52.2M
Q1 24
Debt / Equity
CAPS
CAPS
SLN
SLN
Q3 25
0.43×
Q2 25
0.37×
Q1 25
0.33×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAPS
CAPS
SLN
SLN
Operating Cash FlowLast quarter
$0
$-9.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAPS
CAPS
SLN
SLN
Q3 25
$0
Q2 25
$-1.7M
Q1 25
$-2.3M
Q1 24
$-9.1M
Capex Intensity
CAPS
CAPS
SLN
SLN
Q3 25
0.0%
Q2 25
Q1 25
Q1 24
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAPS
CAPS

Total Stone$12.7M91%
Other$1.3M9%

SLN
SLN

Segment breakdown not available.

Related Comparisons